THC EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
THC's ev/ebitda is lower than 95% of the last 10 years.
EV/EBITDA History
THC EV/EBITDA by year
Yearly range of THC’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 3.1 to 10.0, averaging 6.6.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 3.7 | 5.8 | 7.1 | 4.0 |
| 2025 | 3.1 | 5.2 | 6.7 | 6.2 |
| 2024 | 3.1 | 4.4 | 7.3 | 3.2 |
| 2023 | 6.1 | 6.7 | 7.4 | 6.9 |
| 2022 | 5.2 | 5.8 | 6.3 | 5.9 |
| 2021 | 4.8 | 6.7 | 7.7 | 6.0 |
| 2020 | 6.0 | 7.1 | 8.1 | 6.9 |
| 2019 | 6.6 | 7.6 | 9.0 | 8.1 |
| 2018 | 6.4 | 8.1 | 9.4 | 6.6 |
| 2017 | 7.7 | 8.5 | 10.0 | 9.9 |
| 2016 | 7.3 | 7.3 | 7.5 | 7.3 |
Get notified when THC EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is THC EV/EBITDA High or Low Right Now?
Tenet Healthcare Corporation's EV/EBITDA is currently 4.0, which is near historic low relative to its 10-year historical range. The 10-year median EV/EBITDA for THC is approximately 6.8. See all THC valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.